Evaluation of Pharmacologic Prophylaxis for Venous Thromboembolism in Patients with Chronic Liver Disease
- 1 April 2013
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 33 (4), 375-382
- https://doi.org/10.1002/phar.1218
Abstract
Study Objective To determine whether pharmacologic prophylaxis for venous thromboembolism (VTE) was associated with a decrease in the incidence of VTE or an increased incidence of bleeding in patients with chronic liver disease (CLD). Design Single-center, retrospective cohort analysis. Setting University medical center. Patients A total of 1581 adults with CLD hospitalized over a 3-year period for longer than 24 hours. Measurements and Main Results Medical records were reviewed for the primary outcome of VTE and documented episodes of bleeding during hospitalization and were divided into two groups based on receipt of pharmacologic VTE prophylaxis. During the 1581 hospitalizations, 392 (24.7%) patients received pharmacologic VTE prophylaxis. The incidence of VTE in the prophylaxis group was 0.5% compared with 1.8% in patients without prophylaxis (p=0.05). Documented bleeding rates were lower in the prophylaxis group (2.0% vs 10.3%, p<0.001). Multivariate logistic regression identified active malignancy (odds ratio [OR] 8.76, 95% confidence interval [CI], 2.56–29.58), trauma or surgery during hospitalization (OR 10.29, 95% CI 1.18–89.51), and history of VTE (OR 26.48, 95% CI 6.93–101.16) as risk factors of VTE. Use of pharmacologic VTE prophylaxis was protective against VTE (OR 0.34, 95% CI 0.04–0.88). Conclusion Pharmacologic VTE prophylaxis was associated with a decreased incidence of VTE in patients with CLD without an increased rate of bleeding and should be routinely considered on admission to the hospital. Patients with CLD and active malignancy, trauma or surgery during hospitalization, or history of VTE appear to be at highest risk of VTE and thus warrant pharmacologic prophylaxis. Prospective studies must validate these findings.Keywords
This publication has 30 references indexed in Scilit:
- The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patientsThrombosis Journal, 2011
- Natural anticoagulants can be useful predictors of severity in chronic liver diseaseBlood Coagulation & Fibrinolysis, 2010
- Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic eventsWorld Journal of Gastroenterology, 2009
- Deep Vein Thrombosis and Pulmonary Embolism in Cirrhosis PatientsDigestive Diseases and Sciences, 2008
- High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23 796 consecutive autopsiesJournal of Thrombosis and Haemostasis, 2006
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation testsHepatology, 2005
- Venous Thromboembolism Epidemiology: Implications for Prevention and ManagementSeminars in Thrombosis and Hemostasis, 2002
- A model to predict survival in patients with end-stage liver diseaseHepatology, 2001
- Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhageHepatology, 1986
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973